Clinical Trial Update: Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks [Phase 1, Phase 2]

View source ↗

Summary

A behavioral intervention study aimed at reducing health risks associated with novel antipsychotic medications, conducted in Phase 1 and Phase 2 and completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mental Illness

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Mental Illness | Phase 1, Phase 2 | Status: COMPLETED